Specific tumor accumulation and attractive biodistribution highly supportive of MP0712 clinical development for treatment of DLL3-expressing cancersDosimetry data highlight Radio-DARPins as vector for ...
Teradyne Inc . (NASDAQ:TER) reported its fourth-quarter 2024 earnings, surpassing analyst expectations with an EPS of $0.95 against the forecasted $0.91. Revenue also exceeded projections, reaching ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results